Sun Pharma: an update on generic Eloxatin® injection

17/B, Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai 400 093 India Tel.: (91-22) 6645 5645 Fax.: (91-22) 6645 5685 Registered Office : SPARC, Tandalja, Vadodara – 390 020. India Corporate Office : Acme Plaza, Andheri – Kurla Road, Andheri (East), Mumbai – 400 059. India FOR IMMEDIATE RELEASE Sun Pharma: An update on generic Eloxatin® injection Mumbai, June 26, 2010: Sun Pharma Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the U.S. District Court for the District of New Jersey denied Sun Pharma’s motion to suspend the court's order dated April 22, 2010 which entered a Consent Judgement and Order having the effect of enjoining Sun Pharma from selling a generic oxaliplatin product. Accordingly Sun Pharma will stop selling the product after June 30, 2010. On April 30, 2010 Sun Pharma appealed the court order dated April 22, 2010 and intends to litigate the matter before the United States Court of Appeals for the Federal Circuit. Sun Pharma believes that the grounds for appeal are strong and plans to contest the entry of the Consent Judgement and Order vigorously. On receipt of a favorable judgement from the appellate court, SUN plans to reinitiate the sales of the product. Eloxatin® is a registered trademark of sanofi aventis US LLC. About Sun Pharmaceutical Industries Ltd. Established in 1983, listed since 1994 and headquartered in Indi a, Sun Pharmaceutical Indust ries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an internat ional, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulat ions as branded generics as well as generics in India, US and several other markets across the world. In India, the compan y is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, orthopedics and ophthalmology. The Company has strong skills in product development, process chemistry, and manu facturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com. Contacts Uday Baldota Mira Desai Tel +91 22 6645 5645, Xtn 605 Tel +91 22 6645 5645, Xtn 606 Tel Direct +91 22 66455605 Tel Direct +91 22 66455606 Mobile +91 98670 10529 Mobile +91 98219 23797 E mail [email protected] E mail [email protected]

The release as fetched from its publisher. sunpharma.com ↗